PUBMED FOR HANDHELDS

Journal Abstract Search


83 related items for PubMed ID: 9589380

  • 1. Effect of n-3 polyunsaturated fatty acids on cyclosporine pharmacokinetics in kidney graft recipients: a randomized placebo-controlled study.
    Busnach G, Stragliotto E, Minetti E, Perego A, Brando B, Broggi ML, Civati G.
    J Nephrol; 1998; 11(2):87-93. PubMed ID: 9589380
    [Abstract] [Full Text] [Related]

  • 2. Delayed omega-3 fatty acid supplements in renal transplantation. A double-blind, placebo-controlled study.
    Bennett WM, Carpenter CB, Shapiro ME, Strom TB, Hefty D, Tillman M, Abrams J, Ryan D, Kelley VR.
    Transplantation; 1995 Feb 15; 59(3):352-6. PubMed ID: 7871564
    [Abstract] [Full Text] [Related]

  • 3. [A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation].
    Roy A, Grant DR, Kneteman NM, Tchervenkov JI, Levy GA, Tan A, Hendricks L.
    Ann Chir; 1998 Feb 15; 52(8):716-21. PubMed ID: 9846420
    [Abstract] [Full Text] [Related]

  • 4. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
    Svensson M, Schmidt EB, Jørgensen KA, Christensen JH.
    Nephrol Dial Transplant; 2008 Sep 15; 23(9):2918-24. PubMed ID: 18436564
    [Abstract] [Full Text] [Related]

  • 5. Effect of plasma lipid on pharmacokinetics of ciclosporin and its relationship with plasma prednisolone level in renal transplant patients.
    Sugioka N, Kokuhu T, Okamoto M, Yoshimura N, Ito Y, Shibata N, Takada K.
    J Pharm Pharmacol; 2006 Sep 15; 58(9):1193-200. PubMed ID: 16945177
    [Abstract] [Full Text] [Related]

  • 6. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine.
    Kovarik JM, Kahan BD, Kaplan B, Lorber M, Winkler M, Rouilly M, Gerbeau C, Cambon N, Boger R, Rordorf C, Everolimus Phase 2 Study Group.
    Clin Pharmacol Ther; 2001 Jan 15; 69(1):48-56. PubMed ID: 11180038
    [Abstract] [Full Text] [Related]

  • 7. Parenteral nutrition and cyclosporine: do lipids make a difference? A prospective randomized crossover trial.
    Santos P, Lourenço R, Camilo ME, Oliveira AG, Figueira I, Pereira ME, Ferreira B, Carmo JA, Lacerda JM.
    Clin Nutr; 2001 Feb 15; 20(1):31-6. PubMed ID: 11161541
    [Abstract] [Full Text] [Related]

  • 8. Paired kidney analysis of tacrolimus and cyclosporine microemulsion-based therapy in Chinese cadaveric renal transplant recipients.
    Cheung CY, Wong KM, Chan HW, Liu YL, Chan YH, Wong HS, Chak WL, Choi KS, Chau KF, Li CS.
    Transpl Int; 2006 Aug 15; 19(8):657-66. PubMed ID: 16827683
    [Abstract] [Full Text] [Related]

  • 9. Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses.
    Olbricht C, Wanner C, Eisenhauer T, Kliem V, Doll R, Boddaert M, O'Grady P, Krekler M, Mangold B, Christians U.
    Clin Pharmacol Ther; 1997 Sep 15; 62(3):311-21. PubMed ID: 9333107
    [Abstract] [Full Text] [Related]

  • 10. Optimal cyclosporine therapy--an Indian experience.
    Raj DS, Somiah S, Mani K.
    J Assoc Physicians India; 1996 Jan 15; 44(1):34-6. PubMed ID: 8773092
    [Abstract] [Full Text] [Related]

  • 11. Renal function and lipid metabolism in pregnant renal transplant recipients.
    Czajkowski K, Wójcicka-Bentyn J, Sieńko J, Grymowicz M, Smolarczyk R, Malinowska-Polubiec A, Romejko E.
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun 15; 114(2):155-61. PubMed ID: 15140508
    [Abstract] [Full Text] [Related]

  • 12. Long-term kidney transplant outcomes in patients receiving oil-based or microemulsion formulations of cyclosporine.
    Medina-Pestana JO, Felipe CR, Park SI, Machado PG, Garcia R, Spinelli G, Silva LA, Santos CF, Tedesco-Silva H.
    Transplant Proc; 2004 Mar 15; 36(2 Suppl):74S-79S. PubMed ID: 15041311
    [Abstract] [Full Text] [Related]

  • 13. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients.
    Kobashigawa JA, Patel J, Furukawa H, Moriguchi JD, Yeatman L, Takemoto S, Marquez A, Shaw J, Oeser BT, Subherwal S, Wu GW, Kawano J, Laks H.
    J Heart Lung Transplant; 2006 Apr 15; 25(4):434-9. PubMed ID: 16563974
    [Abstract] [Full Text] [Related]

  • 14. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.
    Oberbauer R, Kreis H, Johnson RW, Mota A, Claesson K, Ruiz JC, Wilczek H, Jamieson N, Henriques AC, Paczek L, Chapman J, Burke JT, Rapamune Maintenance Regimen Study Group.
    Transplantation; 2003 Jul 27; 76(2):364-70. PubMed ID: 12883194
    [Abstract] [Full Text] [Related]

  • 15. The effect of n - 3 PUFA/gamma-cyclodextrin complex on serum lipids in healthy volunteers--a randomized, placebo-controlled, double-blind trial.
    Kobayashi K, Hamazaki K, Fujioka S, Terao K, Yamamoto J, Kobayashi S.
    Asia Pac J Clin Nutr; 2007 Jul 27; 16(3):429-34. PubMed ID: 17704023
    [Abstract] [Full Text] [Related]

  • 16. Co-administration of diltiazem and cyclosporine for kidney transplant recipients: a four year follow-up study.
    Ingsathit A, Sumethkul V, Chalermsanyakorn P, Jirasiritham S.
    J Med Assoc Thai; 2006 Aug 27; 89 Suppl 2():S235-41. PubMed ID: 17044477
    [Abstract] [Full Text] [Related]

  • 17. Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients.
    Romero AJ, Le Pogamp P, Nilsson LG, Wood N.
    Clin Pharmacol Ther; 2002 Apr 27; 71(4):226-34. PubMed ID: 11956505
    [Abstract] [Full Text] [Related]

  • 18. Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion.
    Filler G, Webb NJ, Milford DV, Watson AR, Gellermann J, Tyden G, Grenda R, Vondrak K, Hughes D, Offner G, Griebel M, Brekke IB, McGraw M, Balzar E, Friman S, Trompeter R.
    Pediatr Transplant; 2005 Aug 27; 9(4):498-503. PubMed ID: 16048603
    [Abstract] [Full Text] [Related]

  • 19. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
    Thervet E, Pfeffer P, Scolari MP, Toselli L, Pallardó LM, Chadban S, Pilmore H, Connolly J, Buchler M, Schena FP, Carreño CA, Dandavino R, Cole E.
    Transplantation; 2003 Sep 27; 76(6):903-8. PubMed ID: 14508352
    [Abstract] [Full Text] [Related]

  • 20. Equivalence of cyclosporine blood level assays in patients receiving cyclosporine microemulsion or cyclosporine. The Sandoz Neoral Study Group N103.
    Pescovitz MD, Wong RL, Choc MG, Chang CT.
    Clin Transplant; 1997 Oct 27; 11(5 Pt 1):442-5. PubMed ID: 9361938
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.